R&G is a well-known CRO company rooted in China and facing the world, insists on the customer first, adheres to the service concept of "scientificity, professionalism and innovation", with the purpose of "for human health", and provides global pharmaceutical enterprises with all-round and full chain CRO services for clinical research and development to improve the success rate of drug research and development, reduce the risks, save costs, and shorten the cycle, which has been widely praised in the industry. Since its establishment in 2008, R&G has built an excellent team of nearly 2000 people and becomes a brand-new listed company with mature corporate culture after 14 years of unremitting struggle. It has nearly ten subsidiaries, covering registration affairs, clinical pharmacology, medical affairs and pharmacovigilance, data management and statistical analysis, clinical operations, site management and biological sample analysis. Domestic and foreign top experts lead various professional fields, and form the "Science and Strategy Committee of innovative drugs" of the company, which customizes R&D strategy and top-level design, optimizes clinical trial plan, guides new drug application at home and abroad for global pharmaceutical enterprises, achieving excellent achievements. To date, R&G has served for more than 1000 pharmaceutical enterprises to help many drug and device products. It adopts innovative design and scientific methods and promotes efficient communication with the CDE and FDA to accelerate the launch of drugs and devices. In the trend of internationalization of innovation and regulation, R&G staff will continue to empower global pharmaceutical enterprises to benefit many patients in the context of clinical value-oriented pharmaceutical research and development.